The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
MicroRNAs in cancer: biomarkers, functions and therapy
Open accessAbstract
The emergence of microRNAs has been one of the defining developments in cancer biology over the past decade, and the explosion of knowledge in this area has brought forward new diagnostic and therapeutic opportunities. The importance of microRNAs in cancer has been underlined by the identification of alterations in microRNA target binding sites and the microRNA processing machinery in tumor cells. Clinical trials utilizing microRNA profiling for patient prognosis and clinical response are now underway, and the first microRNA mimic entered the clinic for cancer therapy in 2013. In this article we review the potential applications of microRNAs for the clinical assessment of patient outcome in cancer, as well as in cancer monitoring and therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
1 retracted
HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
Kumar, M. S., Armenteros-Monterroso, E., East, P., Chakravorty, P., Matthews, N., Winslow, M. M., & Downward, J. (2013) · Nature · doi:10.1038/nature12785 · Cited by 255
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
miRBase: tools for microRNA genomics
Griffiths‐Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,432
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E., Zeuzem, S., Rodriguez‐Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. P., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,262
Research works printed but not linked: 1
- Choudhury, 2012, Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells, J. Clin. Invest., 122, 4059, 10.1172/JCI62925 · DOI
Cited by
Sorted by citations
Items 401–500 of 1,000
Papadaki, C., Stoupis, G., Tsalikis, L., Monastirioti, A. A., Papadaki, M. A., Maliotis, N., Stratigos, M., Mastrostamatis, G., Mavroudis, D., & Agelaki, S. (2019) · Oncotarget · doi:10.18632/oncotarget.26629 · Cited by 49
Khandelwal, N., Dey, S. K., Chakravarty, S., & Kumar, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00188 · Cited by 51
Cancer Biomarker Detection With Photonic Crystals-Based Biosensors: An Overview
Sinibaldi, A. (2021) · Journal of Lightwave Technology · doi:10.1109/jlt.2021.3056225 · Cited by 49
Ma, Z., Gu, G., Pan, W., & Chen, X. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s232354 · Cited by 48
Noncoding RNAs in osteosarcoma: Implications for drug resistance
Lin, Z., Xie, X., Lu, S. Y., & Liu, T. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.007 · Cited by 49
Zhu, Q., Zhang, Y., Li, M., Zhang, Y., Zhang, H., Chen, J., Liu, Z., Yuan, P., Yang, Z., & Wang, X. (2023) · Biomarker Research · doi:10.1186/s40364-022-00441-w · Cited by 49
MicroRNA-139-3p indicates a poor prognosis of colon cancer.
Liu, X., Duan, B., Dong, Y., He, C., Zhou, H., Sheng, H., Gao, H., & Zhang, X. (2014) · Europe PMC (PubMed Central) · Cited by 48
YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research
Cheng, W., Chung, I., Tsai, C.-F., Huang, T.-S., Chen, C., Wang, S., Chang, T., Sun, H.-J., Chao, J. Y. C., Cheng, C., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1156 · Cited by 48
Small non-coding RNA biomarkers in sputum for lung cancer diagnosis
Su, Y. Y., Guarnera, M. A., Fang, H., & Jiang, F. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0520-8 · Cited by 48
MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer
Fukagawa, S., Miyata, K., Yotsumoto, F., Kiyoshima, C., Nam, S. O., Anan, H., Katsuda, T., Miyahara, D., 村田, 将., Yagi, H., et al. (2017) · Cancer Science · doi:10.1111/cas.13210 · Cited by 48
Association of MiR-146a Expression and Type 2 Diabetes Mellitus: A Meta-Analysis.
Alipoor, B., Ghaedi, H., Meshkani, R., Torkamandi, S., Saffari, S., Iranpour, M., & Omrani, M. D. (2017) · Europe PMC (PubMed Central) · doi:10.22088/acadpub.bums.6.3.156 · Cited by 48
MicroRNA-107 prevents amyloid-β-induced neurotoxicity and memory impairment in mice
Shu, B., Zhang, X., Du, G., Fu, Q., & Huang, L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3339 · Cited by 49
Pathobiologic Roles of Epstein–Barr Virus-Encoded MicroRNAs in Human Lymphomas
Navari, M., Etebari, M., Ibrahimi, M., Leoncini, L., & Piccaluga, P. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041168 · Cited by 48
Aoki, H., Corn, R. M., & Matthews, B. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111565 · Cited by 48
MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Zhang, H.-C., Du, Y., Chen, L., Yuan, Z., & Cheng, Y. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105064 · Cited by 47
Cai, J., Tang, D., Xiao, H., Liu, E., Li, W., & Shi, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1157793 · Cited by 47
Guo, Y., Lang, X. H., Lü, Z., Wang, J., Li, T., Liao, Y., Jia, C., Zhao, W., & Fang, H. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374022 · Cited by 47
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells
Fabbri, E., Montagner, G., Bianchi, N., Finotti, A., Borgatti, M., Lampronti, I., Cabrini, G., & Gambari, R. (2016) · Oncology Reports · doi:10.3892/or.2016.4676 · Cited by 47
Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy
Wang, P., Henning, S. M., Magyar, C. E., Elshimali, Y., Heber, D., & Vadgama, J. V. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0351-x · Cited by 47
New tumor suppressor microRNAs target glypican-3 in human liver cancer
Cartier, F., Indersie, É., Lesjean, S., Charpentier, J., Hooks, K. B., Ghousein, A., Desplat, A., Dugot‐Senant, N., Trézéguet, V., Sagliocco, F. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17162 · Cited by 47
miR-206-3p Inhibits 3T3-L1 Cell Adipogenesis via the c-Met/PI3K/Akt Pathway
Tang, R., Ma, F., Li, W., Ouyang, S., Liu, Z., & Wu, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071510 · Cited by 47
Fasihi, A., Soltani, B. M., Atashi, A., & Nasiri, S. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26357 · Cited by 47
Paxillin family of focal adhesion adaptor proteins and regulation of cancer cell invasion
Alpha, K. M., Xu, W., & Turner, C. E. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.05.003 · Cited by 50
Nuclear Factor κB Signaling and Its Related Non-coding RNAs in Cancer Therapy
Liu, X., Shao, Y., Zhou, J., Qian, G., & Ma, Z. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.007 · Cited by 46
Y RNAs: Biogenesis, Function and Implications for the Cardiovascular System
Valkov, N., & Das, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1671-9_20 · Cited by 46
Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis
Zhan, S., Yang, P., Zhou, S., Xu, Y., Xu, R. C., Liang, G., Zhang, C., Chen, X., Yang, L., Jin, F., et al. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0920-7 · Cited by 46
microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance
Fattahi, M., Rezaee, D., Fakhari, F., Najafi, S., Zarch, S. M. A., Beyranvand, P., Rashidi, M. A., Bagheri‐Mohammadi, S., Rarani, F. Z., Bakhtiari, M., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01718-1 · Cited by 46
Function of microRNA-143 in different signal pathways in cancer: New insights into cancer therapy
Karimi, L., Mansoori, B., Shanebandi, D., Mohammadi, A., Aghapour, M., & Baradaran, B. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.060 · Cited by 46
miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1
Santasusagna, S., Moreno, I., Navarro, A., Muñoz, C., Martinez, F., Hernández, R., Castellano, J. J., & Monzó, M. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-1836-1 · Cited by 46
Epigenetics and testicular germ cell tumors
Buljubašić, R., Buljubašić, M., Bojanac, A. K., Ulamec, M., Vlahović, M., Ježek, D., Bulić‐Jakuš, F., & Sinčić, N. (2018) · Gene · doi:10.1016/j.gene.2018.03.072 · Cited by 46
Hu, Y., Dingerdissen, H., Gupta, S., Kahsay, R., Shanker, V. K., Wan, Q., Yan, C., & Mazumder, R. (2018) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2018.10.021 · Cited by 46
Yu, Y., & Cao, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0984-x · Cited by 46
Chen, C., Yin, P., Hu, S., Sun, X., & Li, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117924 · Cited by 45
Yu, M., Ozaki, T., Sun, D., Xing, H., Wei, B., An, J., Yang, J., Gao, Y., Liu, S., Kong, C., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01613-y · Cited by 45
Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis
Shahjahani, M., Asl, J. M., Norozi, F., Seghatoleslami, M., Shahrabi, S., Saba, F., & Saki, N. (2015) · Cellular Oncology · doi:10.1007/s13402-014-0215-3 · Cited by 48
RETRACTED: MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1
Han, N., Zhao, W., Zhang, Z., & Zheng, P. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.020 · Cited by 45
RetractedMiR-153 promotes breast cancer cell apoptosis by targeting HECTD3.
Wu, X., Li, L., Li, Y., & Liu, Z. (2016) · Europe PMC (PubMed Central) · Cited by 45
miR-1247-5p functions as a tumor suppressor in human hepatocellular carcinoma by targeting Wnt3
Chu, Y., Fan, W., Guo, W., Zhang, Y., Wang, L., Guo, L., Duan, X., Wei, J., & Xu, G. (2017) · Oncology Reports · doi:10.3892/or.2017.5702 · Cited by 45
Gupta, S. K., Maclean, P. H., Ganesh, S., Shu, D., Buddle, B. M., Wedlock, D. N., & Heiser, A. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-14785 · Cited by 48
Circulating miR‐26a and miR‐21 as biomarkers for glioblastoma multiform
ParvizHamidi, M., Haddad, G., Ostadrahimi, S., Ostadrahimi, N., Sadeghi, S., Fayaz, S., & Fard‐Esfahani, P. (2018) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1707 · Cited by 45
Towards control of cellular decision-making networks in the epithelial-to-mesenchymal transition
Zañudo, J. G. T., Guinn, M. T., Farquhar, K. S., Szenk, M., Steinway, S. N., Balázsi, G., & Albert, R. (2019) · Physical Biology · doi:10.1088/1478-3975/aaffa1 · Cited by 47
Xiao, J., Lai, H., Wei, S., Ye, Z., Gong, F., & Chen, L. (2019) · Cancer Medicine · doi:10.1002/cam4.1302 · Cited by 45
RetractedLi, G., Tan, W., Fang, Y., Wu, X., Zhou, W., Zhang, C., Zhang, Y., Liu, Y., Jiu, G., & Liu, D. (2019) · Aging · doi:10.18632/aging.101986 · Cited by 45
Meng, L., Chen, Z., Jiang, Z., Huang, T., Hu, J., Luo, P.-Q., Zhang, H., Huang, M., Huang, L., Chen, Y., et al. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz141 · Cited by 45
Yang, L.-D., Zhang, L., Lu, L., & Wang, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s235862 · Cited by 45
Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer
Abbastabar, M., Sarfi, M., Golestani, A., Karimi, A., Pourmand, G., & Khalili, E. (2019) · EXCLI journal · doi:10.17179/excli2019-1683 · Cited by 45
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
Motti, M. L., Minopoli, M., Carluccio, G. D., Ascierto, P. A., & Carriero, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124544 · Cited by 45
Circulating microRNA as a Biomarker for Coronary Artery Disease
Fazmin, I. T., Achercouk, Z., Edling, C. E., Said, A., & Jeevaratnam, K. (2020) · Biomolecules · doi:10.3390/biom10101354 · Cited by 46
Egloff, S., Melnychuk, N., Reisch, A., Martin, S., & Klymchenko, A. S. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113084 · Cited by 46
Alexandrova, E., Miglino, N., Hashim, A., Nassa, G., Stellato, C., Tamm, M., Baty, F., Brutsche, M. H., Weisz, A., & Borger, P. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.031 · Cited by 45
Qi, Z., Zhao, Y., Su, Y., Cao, B., Yang, J.-J., & Xing, Q. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.685088 · Cited by 44
Wu, W., Dang, S., Feng, Q., Liang, J., Wang, Y., & Fan, N. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.136 · Cited by 44
MiR-572 prompted cell proliferation of human ovarian cancer cells by suppressing PPP2R2C expression
Wu, A., Huang, Y., Zhang, L., Tian, G., Liao, Q.-Z., & Chen, S. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.005 · Cited by 44
Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade
Rambow, F., Bechadergue, A., Luciani, F., Gros, G., Domingues, M. J., Bonaventure, J., Meurice, G., Marine, J., & Larue, L. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.02.803 · Cited by 45
MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis
Wang, Y., Zeng, J., Pan, J., Geng, X., Li, L., Wu, J., Song, P., Wang, Y., Liu, J., & Wang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.8676 · Cited by 44
Methods and novel technology for microRNA quantification in colorectal cancer screening
Moody, L., He, H., Pan, Y.-X., & Chen, H. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0420-9 · Cited by 42
Distinguishing mirtrons from canonical miRNAs with data exploration and machine learning methods
Rorbach, G., Unold, O., & Konopka, B. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25578-3 · Cited by 45
Quan, H., Li, B., & Yang, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.150 · Cited by 44
MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology
Sun, G., Ding, X., Bi, N., Wu, L., Wang, J., Zhang, W., Dong, X., Lv, N., Song, Y., Zhan, Q., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0955-5 · Cited by 44
Graphene oxide-based NET strategy for enhanced colorimetric sensing of miRNA
Lee, J., Kim, Y., Lee, S., Yoon, S., & Kim, W.-K. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.11.149 · Cited by 44
Cerebrospinal fluid biomarkers for brain tumor detection: clinical roles and current progress.
Xiao, F., Lv, S., Zong, Z., Wu, L., Tang, X., Kuang, W., Zhang, P., Li, X., Fu, J., Xiao, M., et al. (2020) · PubMed Central · Cited by 44
The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma
Shi, Z., Wang, W., Chen, Y., Fan, Z.-W., Xie, X., Yang, L.-Y., Chen, C., Cai, Y., Hao, J., Wang, M., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02801-6 · Cited by 44
MicroRNAs: At the Interface of Metabolic Pathways and Inflammatory Responses by Macrophages
Nelson, M. C., & O’Connell, R. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01797 · Cited by 45
MicroRNA‐195 controls MICU1 expression and tumor growth in ovarian cancer
Rao, G., Dwivedi, S. K. D., Zhang, Y., Dey, A., Shameer, K., Karthik, R., Srikantan, S., Hossen, M. N., Wren, J. D., Madesh, M., et al. (2020) · EMBO Reports · doi:10.15252/embr.201948483 · Cited by 44
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes
Santovito, D., Toto, L., Nardis, V. D., Marcantonio, P., D’Aloisio, R., Mastropasqua, A., Cesare, D. D., Bucci, M., Paganelli, C., Natarelli, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83047-w · Cited by 45
Molecular mechanisms of the microRNA-132 during tumor progressions
Moghbeli, M., Zangouei, A. S., Navaei, Z. N., & Taghehchian, N. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02149-7 · Cited by 44
miRNAs as therapeutic tools and biomarkers for prostate cancer
Arrighetti, N., & Beretta, G. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030380 · Cited by 43
Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1
Renrick, A. N., Thounaojam, M. C., de Aquino, M. T. P., Chaudhuri, E., Pandhare, J., Dash, C., & Shanker, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.607044 · Cited by 43
miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2
Chen, J., Zhou, J., Chen, X., Yang, B., Wang, D., Yang, P., He, X., & Li, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-3568-y · Cited by 43
Lv, X., Li, Y., Zhang, J., Han, P., & Li, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5394 · Cited by 43
Hypoxia‐induced microRNA‐301b regulates apoptosis by targeting Bim in lung cancer
Wu, D., Chen, B., Cui, F., He, X., Wang, W., & Wang, M. (2016) · Cell Proliferation · doi:10.1111/cpr.12264 · Cited by 43
MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer
Xin, R., Bai, F., Feng, Y., Jiu, M., Liu, X., Bai, F., Nie, Y., & Fan, D. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.05.006 · Cited by 43
Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers
Mokhtarzadeh, A., Hassanpour, S., Vahid, Z. F., Hejazi, M., Hashemi, M., Ranjbari, J., Tabarzad, M., Noorolyai, S., & de la Guárdia, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.028 · Cited by 43
Świtlik, W. Z., Karbownik, M. S., Suwalski, M., Kozak, J., & Szemraj, J. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170767 · Cited by 43
Li, M., Han, Y., Zhou, H., Li, X., Lin, C., Zhang, E., Chi, X., Hu, J., & Xu, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0128-y · Cited by 43
miRNA arm switching identifies novel tumour biomarkers
Chen, L., Sun, H., Wang, C., Yang, Y., Zhang, M., & Wong, G. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.11.003 · Cited by 44
A new insight on serum microRNA expression as novel biomarkers in breast cancer patients
Bahmanpour, Z., Sheervalilou, R., Choupani, J., Khaniani, M. S., Montazeri, V., & Derakhshan, S. M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28656 · Cited by 43
Xu, Y., Jiang, W., Zhong, L., Li, H., Bai, L., Chen, X., Lin, Y., & Zheng, D. (2020) · Aging · doi:10.18632/aging.103160 · Cited by 43
Palma, F. D. E. D., Luglio, G., Tropeano, F. P., Pagano, G., D'Armiento, M. R., Kroemer, G., Maiuri, M. C., & Palma, G. D. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197040 · Cited by 43
Chen, Z., Liang, Y., Feng, X., Yu, L., Shen, G., Huang, H., Chen, Z., Yu, J., Liu, H., Tian, L., et al. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111722 · Cited by 43
Lu, Y., Zhang, B., Wang, B., Wu, D., Wang, C., Gao, Y., Liang, W., Xi, H., Wang, X., & Chen, L. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03093-w · Cited by 43
miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.
Li, N., Yu, N., Wang, J., Xi, H., Lu, W., Xu, H., Deng, M., Zheng, G., & Liu, H. (2015) · PubMed Central · Cited by 43
Muñoz, J. J. A. M., Drigo, S. A., Barros‐Filho, M. C., Marchi, F. A., Scapulatempo‐Neto, C., Pessôa, G. D. S., Guimarães, G. C., Filho, J. C. S. T., Lopes, A., Arruda, M. A. Z., et al. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.11.097 · Cited by 42
Noncoding RNAs in Cancer Development
Lin, C., & He, L. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-034443 · Cited by 42
Cañueto, J., Cardeñoso‐Álvarez, E., García‐Hernández, J. L., Galindo‐Villardón, P., Vicente‐Galindo, P., Villardón, J. L. V., Alonso‐López, D., Rivas, J. D. L., Valero, J., Moyano‐Sanz, E., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15236 · Cited by 42
Lu, Y., Cheng, A., Lee, L., You, G.-R., Li, Y.-L., Chen, H.-Y., & Chang, J. T. (2017) · Scientific Reports · doi:10.1038/s41598-017-02058-8 · Cited by 42
Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer
Yeh, W., Tsai, C., & Chen, D. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0630-2 · Cited by 42
MicroRNA‐451a acts as tumor suppressor in cutaneous basal cell carcinoma
Sun, H., & Jiang, P. (2018) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.473 · Cited by 42
Chen, Z., Zhuang, W., Wang, Z., Xiao, W., Don, W., Li, X., & Chen, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29196 · Cited by 42
Ghousein, A., Mosca, N., Cartier, F., Charpentier, J., Dupuy, J., Raymond, A., Bioulac‐Sage, P., & Grosset, C. F. (2019) · Liver International · doi:10.1111/liv.14276 · Cited by 43
Katsaraki, K., Karousi, P., Artemaki, P. I., Scorilas, A., Pappa, V., Kontos, C. K., & Papageorgiou, S. G. (2021) · Cancers · doi:10.3390/cancers13040593 · Cited by 42
Androgen Receptor-Related Non-coding RNAs in Prostate Cancer
Yang, Y., Liu, K. Y., Liu, Q., & Cao, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660853 · Cited by 43
Shao, L., He, Q., Wang, J., He, F., Lin, S., Wu, L., Gao, Y., Ma, W., Dong, J., Yang, X., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00527-8 · Cited by 43
Zang, H.-L., Li, Y., Zhang, X., & Huang, G. (2020) · Cancer Management and Research · doi:10.2147/cmar.s243300 · Cited by 41
RetractedmicroRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics
Martino, S., Tammaro, C., Misso, G., Falco, M., Scrima, M., Bocchetti, M., Rea, I., Stefano, L. D., & Caraglia, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097762 · Cited by 42
Garrido‐Cano, I., Adam‐Artigues, A., Lameirinhas, A., Blandez, J. F., Candela‐Noguera, V., Lluch, A. M., Bermejo, B., Sancenón, F., Cejalvo, J. M., Martínez‐Máñez, R., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c07541 · Cited by 41
Integrated proteo-genomic approach for early diagnosis and prognosis of cancer
Shukla, H. D., Mahmood, J., & Vujašković, Ž. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.003 · Cited by 42
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth
Hoareau‐Aveilla, C., Valentin, T., Daugrois, C., Quelen, C., Mitou, G., Quentin, S., Jinsong, J., Spicuglia, S., Ferrier, P., Ceccon, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78488 · Cited by 47
Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy
Amstutz, U., Offer, S. M., Sistonen, J., Joerger, M., Diasio, R. B., & Largiadèr, C. R. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2817 · Cited by 41
Dong, W., Yang, L., Lv, B., & Chen, L. (2017) · PubMed Central · Cited by 41
Metadata
- Authors
- Hayes, J., Peruzzi, P. P., & Lawler, S.
- Affiliations
- St James's University Hospital (GB)
- The Ohio State University Wexner Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Lawler, Sean
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 20
- Issue
- 8
- Pages
- 460-469
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1974254202
- Cited by
- 2,049
- References
- 79
- Citations by year
- 2026: 61 · 2025: 78 · 2024: 103 · 2023: 130 · 2022: 186 · 2021: 244 · 2020: 290 · 2019: 273 · 2018: 235 · 2017: 203 · 2016: 140 · 2015: 91 · 2014: 12
- FWCI
- 14.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- microRNA, cancer, biomarkers, microRNA processing, miRNA expression profiling, prognosis, cancer therapy, miRNA mimics, cancer monitoring
- MeSH terms
- Animals, Humans, Neoplasms, Prognosis, Biomarkers, Tumor, Genetic Therapy, Gene Expression Regulation, Neoplastic, MicroRNAs, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review